122 related articles for article (PubMed ID: 31151972)
1. Miliary pattern on chest imaging as a presentation of EGFR-negative primary lung adenocarcinoma.
Hoffman SA; Manski S; Deepak J
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31151972
[TBL] [Abstract][Full Text] [Related]
2. Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.
Kunishige M; Takeuchi E
Thorac Cancer; 2023 Dec; 14(34):3419-3420. PubMed ID: 37920971
[TBL] [Abstract][Full Text] [Related]
3. [Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma].
Dumoulin J; Rozensztajn N; Paradis M; Sellier J; Abel A; Giraud P; Labrune S; Chinet T
Rev Mal Respir; 2016 Jan; 33(1):67-71. PubMed ID: 25794997
[TBL] [Abstract][Full Text] [Related]
4. [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].
Li L; Zhou L; Zhang J
Zhongguo Fei Ai Za Zhi; 2019 Dec; 22(12):798-804. PubMed ID: 31874677
[TBL] [Abstract][Full Text] [Related]
5. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
Togashi Y; Masago K; Kubo T; Sakamori Y; Kim YH; Hatachi Y; Fukuhara A; Mio T; Togashi K; Mishima M
Cancer; 2011 Feb; 117(4):819-25. PubMed ID: 20886633
[TBL] [Abstract][Full Text] [Related]
6. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive miliary brain metastasis of lung cancer after EGFR tyrosine kinase inhibitor discontinuation: An autopsy report.
Kurihara M; Koda H; Aono H; Sugimoto I; Sakurai Y; Sano T; Saito Y; Murayama S; Mori M
Neuropathology; 2019 Apr; 39(2):147-155. PubMed ID: 30868686
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
[TBL] [Abstract][Full Text] [Related]
9. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
10. Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.
Liang JY; Tong F; Gu FF; Liu YY; Zeng YL; Hong XH; Zhang K; Liu L
Medicine (Baltimore); 2017 May; 96(21):e6985. PubMed ID: 28538405
[TBL] [Abstract][Full Text] [Related]
11. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
[TBL] [Abstract][Full Text] [Related]
12. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
13. Unusual synchronous double primary treatment-naïve lung adenocarcinoma harboring T790M and L858R mutations in early-stage lung cancer.
Weng CF; Chen PJ; Tseng AH; Huang SH; Lee HH
World J Surg Oncol; 2019 Aug; 17(1):148. PubMed ID: 31426797
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
Markóczy Z; Sárosi V; Kudaba I; Gálffy G; Turay ÜY; Demirkazik A; Purkalne G; Somfay A; Pápai-Székely Z; Rásó E; Ostoros G
BMC Cancer; 2018 May; 18(1):598. PubMed ID: 29801465
[TBL] [Abstract][Full Text] [Related]
15. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.
Hsu F; Nichol A; Toriumi T; De Caluwe A
Acta Oncol; 2017 Sep; 56(9):1175-1180. PubMed ID: 28521651
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status.
Han L; Lee CK; Pang H; Chan HT; Lo IL; Lam SK; Cheong TH; Ho JC
Lung Cancer; 2017 Dec; 114():79-89. PubMed ID: 29173771
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma.
Riudavets M; Bosch-Barrera J; Cabezón-Gutiérrez L; Diz Taín P; Hernández A; Alonso M; Blanco R; Gálvez E; Insa A; Mielgo X; Morán T; Ponce S; Roa D; Sánchez JM; Majem M
Clin Transl Oncol; 2021 Dec; 23(12):2560-2567. PubMed ID: 34292495
[TBL] [Abstract][Full Text] [Related]
18. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients.
Hsiao SH; Lin HC; Chou YT; Lin SE; Kuo CC; Yu MC; Chung CL
Lung Cancer; 2013 Sep; 81(3):455-461. PubMed ID: 23871711
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
Kwon BS; Cho YH; Yoon SK; Lee DH; Kim SW; Kwon DH; Lee JC; Choi CM
Thorac Cancer; 2020 Feb; 11(2):436-442. PubMed ID: 31910497
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].
Zhang XD; Liu DR
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):640-644. PubMed ID: 30122764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
